Status of renal replacement therapy and peritoneal dialysis in Mexico

Peritoneal Dialysis International

Volumn 27, Issue 2, 2007, Pages 142-148

  Cueto Manzano, Alfonso M ^a   Rojas Campos, Enrique ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Diabetes mellitus; Malnutrition; Mexico

Indexed keywords

OVALBUMIN;

AGING; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIET SUPPLEMENTATION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH CENTER; HEALTH INSURANCE; HEMODIALYSIS; HUMAN; HYPOALBUMINEMIA; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALNUTRITION; MEDICAL CARE; MEXICO; MORTALITY; PERITONEAL DIALYSIS; PERITONITIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RESOURCE ALLOCATION; RISK FACTOR; SOCIAL SECURITY; SURVIVAL RATE; TREATMENT FAILURE;

EID: 34249008696     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700207     Document Type: Article

References (38)

1. The World Bank Group (accessed July, 2005): http://www.worldbank.org
2. The United Nations Economic Commission for Latin America (CEPAL) (accessed July, 2005): http://www.cepal.org
3. Secretaría de Salud (accessed July, 2005): http://www.salud.gob.mx
4. Instituto Nacional de Estadística, Geografía e Informática (accessed July, 2005): http://www.inegi.gob.mx
5. García-García G, Monteon-Ramos JF, García-Bejarano H, Gomez-Navarro B, Hernandez Reyes I, Lomeli AM, et al. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL). Kidney Int Suppl 2005; 97:S58-61.
6. Centro Nacional de Trasplantes (accessed July, 2005): http://www.cenatra.gob.mx
7. Breien Alcaraz H, García Bejarano H, García García G, Gómez Navarro B, Hernández Reyes I, Lomeli AM, et al. Epidemiología de la insuficiencia renal crónica en Jalisco. Boletín del Colegio Jalisciense Nefrología 2001; 5:6-8.
8. Cusumano AM, Di Gioia C, Hermida O, Lavorato C, on behalf of the Latin American Registry of Dialysis and Renal Transplantation. The Latin American Dialysis and Renal Transplantation Registry annual report 2002. Kidney Int Suppl 2005; 97:S46-52.
9. Cueto-Manzano AM. Peritoneal dialysis in Mexico. Kidney Int Suppl 2003; 83:S90-2.
10. Westman J. Worldwide dialysis update. In: Annual Survey. Deerfield, IL: Baxter Healthcare Inc.; 1993.
11. Su-Henrández L, Abascal-Macias A, Mendez-Bueno FJ, Paniagua R, Amato D. Epidemiologic and demographic aspects of peritoneal dialysis in Mexico. Perit Dial Int 1996; 16:362-5.
12. United States Renal Data System (accessed: July, 2005): http://www.usrds.org
13. Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) (accessed: July, 2005): http://www.anzdata.org.au
14. European Renal Association and European Dialysis and Transplantation Association (ERA-EDTA) Registry (accessed: July, 2005): http://www.era-edta-reg.org/index.jsp.
15. Sociedad Latino-Americana de Nefrología e Hipertensión (SLANH) (accessed: July, 2005): http://www.slanh.org.
16. Otero Cagide F, Schettino MA, Rodríguez Rodríguez A, Aguilar Martinez C, Barzalobre Sanchez A, Cardona Chavez JG, et al. Cost effectiveness analysis in patients with chronic renal insufficiency in dialysis. Nefrología Mexicana 2002; 23:147-56.
17. Cueto-Manzano AM, Rojas-Campos E, Rosales G, Gómez B, Martinez HR, Cortés-Sanabria L, et al. Risk factors for long-term graft lost in kidney transplantation: experience of a Mexican single center. Rev Invest Clin 2002; 54:492-6.
18. Sabath E, Vega O, Correa-Rotter R. Referencia temprana al nefrólogo: impacto sobre la hospitalización inicialy los seis primeros meses en diálisis peritoneal continua ambulatoria. Rev Invest Clin 2003; 55:489-93.
19. Cueto-Manzano AM, Quintana-Piña E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single center. Perit Dial Int 2001; 21:148-53.
20. Garcia G, Briseño G, Luquin H, Ibarra M, Cueto A. Timing of dialysis initiation and patient survival among disadvantaged populations in Mexico [Abstract SA-PO402]. J Am Soc Nephrol 2004; 15:390A.
21. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
22. Gamba G, Mejia JL, Saldivar S, Pena JC, Correa-Rotter R. Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron 1993; 65: 23-7.
23. Cueto-Manzano AM, Correa-Rotter R. Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000; 57:314-20.
24. Lerman IG, Villa AR, Martinez CL, Cervantes Turrubiatez L, Aguilar Salinas CA, Wong B, et al. The prevalence of diabetes and associated coronary risk factors in urban and rural older Mexican populations. J Am Geriatr Soc 1998; 46:1387-95.
25. West SK, Klein R, Rodriguez J, Muñoz B, Broman AT, Sanchez R, et al. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care 2001; 24:1204-9.
26. Velazquez-Monroy O, Rosas Peralta M, Lara Esqueda A, Pastelin Hernandez G, Sanchez-Castillo C, Attie F, et al. Prevalence and interrelations of noncommunicable chronic diseases and cardiovascular risk factors in Mexico. Arch Cardiol Mex 2003; 73:62-77.
27. Cueto-Manzano AM, Cortés-Sanabria L, Martínez-Ramírez HR, Rojas-Campos E, Barragan G, Alfaro G, et al. Detection of early nephropathy in Mexican type 2 diabetes mellitus patients. Kidney Int Suppl 2005; 97: S40-5.
28. Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, et al. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis 2006; 47:78-87.
29. Consejo Nacional de Población (accessed: February, 2006): http://www.conapo.gob.mx
30. Treviño A. La Insuficiencia Renal Crónica en México. Mexico City; Editorial Manual Moderno; 2001.
31. Espinosa A, Cueto-Manzano A, Velázquez C, Hernández A, Cruz N, Zamora B, et al. Prevalence of malnutrition in Mexican CAPD diabetic and non-diabetic patients. Adv Perit Dial 1996; 12:302-6.
32. González-Espinoza L, Gutiérrez-Chávez J, Martín del Campo F, Martínez-Ramírez HR, Cortés-Sanabria L, Rojas-Campos E, et al. Randomized, open-labeled, controlled clinical trial of the oral administration of an egg albumin-based protein supplement on continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2005; 25:173-80.
33. Díaz A, Gamba G, Abasta-Jiménez M, Correa-Rotter R. Serum albumin and body surface area are the strongest predictors of the peritoneal transport type. Adv Perit Dial 1994; 10:47-51.
34. Cueto-Manzano AM, Gamba G, Correa-Rotter R. Peritoneal protein loss in patients with high peritoneal permeability. Comparison between continuous ambulatory peritoneal dialysis and daytime intermittent dialysis. Arch Med Res 2001; 32:197-201.
35. Cueto-Manzano AM, Espinosa A, Hernández A, Correa-Rotter R. Peritoneal transport kinetics correlate with serum albumin but not with the overall nutritional status in CAPD patients. Am J Kidney Dis 1997; 30:229-36.
36. Cueto-Manzano AM, Salazar M, Valera-Gonzalez I, Rojas-Campos E, Martinez-Ramirez HR, Cortes-Sanabria L, et al. Association between the peritoneal transport rate and systemic inflammation marker in continuous ambulatory peritoneal dialysis (CAPD) [Abstract]. J Am Soc Nephrol 2002; 13:201A.
37. Monteón F, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, et al. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. Kidney Int 1998; 54:2123-8.
38. Garcia G, Tachiquin N, Ibarra M, Luquin H, Cueto A. Risk of peritonitis among poor CAPD patients in Mexico [Abstract SU-PO290]. J Am Soc Nephrol 2004; 15:597A.